Figure 4 | British Journal of Cancer

Figure 4

From: A comparative study between catalase gene therapy and the cardioprotector monohydroxyethylrutoside (MonoHER) in protecting against doxorubicin-induced cardiotoxicity in vitro

Figure 4

Protective effect of preinfection with AdCat (MOI 50) or cotreatment with 1 mM monoHER against doxorubicin-induced LDH release (A) and survival (B) of NeRCaMs 2 days after doxorubicin treatment. Values are mean (n=3) ± s.e.m. The P-values, which indicate significant protection against doxorubicin damage, were calculated by the ANOVA of multiple regression of ln (survival or LDH release) vs ln doxorubicin concentration alone, with 1 mM monoHER or with AdCat (MOI 50) preinfection.

Back to article page